2
views
0
recommends
+1 Recommend
4 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          With the outbreak of the COVID-19 pandemia, routine clinical work was immediately, deeply, and sustainably impacted in Germany and worldwide. The infrastructure of almost all hospitals is currently redirected to provide a maximum of intensive care resources, including the necessary staff. In parallel, routine as well as emergency clinical care for all patients in need has to be secured. This challenge becomes particularly evident in cancer care. In order to maintain adequate oncological care at all levels of provision and to conduct especially curative and intensive treatments with a maximum of safety, continuous adaption of the oncology care system has to be ensured. Intensive communication with colleagues and patients is needed as is consequent expert networking and continuous reflection of the own developed strategies. In parallel, it is of high importance to actively avoid cessation of innovation in order not to endanger the continuous improvement in prognosis of cancer patients. This includes sustained conduction of clinical trials as well as ongoing translational research. Here, we describe measures taken at the University Cancer Center Hamburg (UCCH) − a recognized comprehensive oncology center of excellence − during the COVID-19 crisis. We aim to provide support and potential perspectives to generate a discussion basis on how to maintain high-end cancer care during such a crisis and how to conduct patients safely into the future.

          Related collections

          Most cited references 1

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          COVID-19: Global radiation oncology’s targeted response for pandemic preparedness

          Highlights • COVID-19 requires measures to reduce infection spread between patients and the radiation oncology workforce. • Planning is required to create capacity and continue essential treatments despite a reduced workforce. • This document summarises discussions held during an urgent online Twitter #radonc journal club. • Themes are infection prevention, reducing fractions and treatment policies in the presence of infection.
            Bookmark

            Author and article information

            Journal
            Oncol Res Treat
            Oncol Res Treat
            ORT
            Oncology Research and Treatment
            S. Karger GmbH (Wilhelmstrasse 20A, P.O. Box · Postfach · Case postale, D–79095, Freiburg, Germany · Deutschland · Allemagne, Phone: +49 761 45 20 70, Fax: +49 761 4 52 07 14, information@karger.de )
            2296-5270
            2296-5262
            7 May 2020
            : 1-7
            Affiliations
            [1 ] aUniversity Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
            [2 ] bInstitute for Medical Microbiology, Virology and Hygiene, Department for Infection Prevention and Control, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
            Author notes
            *Carsten Bokemeyer, UCCH, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, DE–20246 Hamburg (Germany), cbokemeyer@ 123456uke.de
            Article
            ort-0001
            10.1159/000508272
            7251567
            32380501
            Copyright © 2020 by S. Karger AG, Basel

            This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

            Page count
            Figures: 1, References: 8, Pages: 7
            Categories
            Review Article

            covid-19, sars-cov-2, cancer care

            Comments

            Comment on this article